VariZig
- Product NDC
- 70257-126
- 11-digit product format
- 702570126
- Labeler code
- 70257
- Product ID
- 70257-126_272379b7-f0e7-4560-8d79-3fd0024c3010
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Varicella Zoster Immune Globulin (Human)
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR
- Labeler
- Saol Therapeutics Inc.
- Application
- BLA125430
- Marketing category
- BLA
- Marketing start
- 2019-03-01
- Marketing end
- 0000-00-00
- Substance
- HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN
- Active strength
- 125 [iU]/mL
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70257-126 | VARIZIG (HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN) SOLUTION [SAOL THERAPEUTICS] | 3 | Legacy NDC | 20230331_1cec80c5-a2b3-459f-959e-d6febfd2671c.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70257-126-51 | 70257012651 | 1 VIAL in 1 CARTON (70257-126-51) > 1.25 mL in 1 VIAL (70257-126-11) | 1 vial | 2019-03-01 | 0000-00-00 | No | No | Current |